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Abstract
The crystal structure of the high affinity Escherichia coli MetNI methionine uptake transporter, a
member of the ATP Binding Cassette (ABC) family, has been solved to 3.7 Å resolution. The
overall architecture of MetNI reveals two copies of the ATPase MetN in complex with two copies
of the transmembrane domain MetI, with the transporter adopting an inward-facing conformation
exhibiting widely separated nucleotide binding domains. Each MetI subunit is organized around a
core of five transmembrane helices that correspond to a subset of the helices observed in the larger
membrane spanning subunits of the molybdate ModBC and maltose MalFGK ABC transporters.
In addition to the conserved nucleotide binding domain of the ABC family, MetN contains a C-
terminal extension belonging to the ACT-domain family previously proposed to represent a
conserved regulatory binding fold. These domains separate the nucleotide binding domains and
would interfere with their association required for ATP binding and hydrolysis. Methionine binds
to the dimerized C-terminal domain and is shown to inhibit ATPase activity. These observations
are consistent with an allosteric regulatory mechanism operating at the level of transport activity,
where increased intracellular levels of the transported ligand stabilize an inward-facing, ATPase-
inactive state of MetNI to inhibit further ligand translocation into the cell.
The high affinity uptake of methionine by Escherichia coli is mediated by the MetD system
(1, 2), a member of the methionine uptake transporter family (3) of ATP Binding Cassette
(ABC) transporters (4-8). ABC transporters such as MetD translocate substrates across the
membrane, a process that is coupled to the hydrolysis of ATP by a cytoplasmic nucleotide
binding domain (NBD). Architecturally, an ABC transporter contains four domains, two
NBDs responsible for the interactions with ATP and two transmembrane domains (TMDs)
that form the translocation pathway; the NBD and TMD components of the E. coli MetD
system have been identified as MetN and MetI, respectively (9, 10). Substrate translocation
by ABC transporters may be described in terms of an alternating access model that involves
the interconversion of outward- and inward-facing conformations driven by the binding and
hydrolysis of ATP by the NBDs. Additional domains of diverse structure may be fused to
the TMDs or NBDs to regulate transport activity (11); examples include ionic strength
sensing by OpuA (12), the inducer exclusion phenomenon mediated by MalK (13), and post-
translational modifications of the cystic fibrosis transmembrane conductance regulator (14).
Structural studies of the intact ABC importers for vitamin B12 (BtuCD, (15, 16)) and the
homologous HI1470/71 (17), molybdate (ModBC, (18)) and maltose (MalFGK, (19)), and
the exporters Sav1866 (20) and MsbA (21) have established the basic molecular architecture
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of ABC transporters and have provided structural models for some of the states of the
transport cycle.
The MetD system was originally identified as an importer of both L- and D-methionine,
either of which may be used as a source of methionine by E. coli (2, 22). MetD is
additionally capable of transporting L-selenomethionine and other methionine derivatives.
Intriguingly, early studies by Kadner (23) established the phenomenon of trans-inhibition in
this system, whereby uptake of external methionine is inhibited by intracellular methionine
levels in a fashion consistent with the direct action of methionine on the transporter. To
further investigate this system, we have determined the crystal structure at 3.7 Å resolution
of the E. coli methionine ABC transporter MetNI solubilized in the detergent
dodecylmaltoside (24). The crystallographic analyses, together with kinetic studies, indicate
that the binding of methionine to the C-terminal domain of the ABC subunits stabilizes an
inward-facing, ATPase-inactive conformation of the transporter, and provide a structural
basis for the regulatory properties discovered by Kadner.
The overall architecture of MetNI consists of two copies of the ATPase MetN in complex
with two copies of the transmembrane domain MetI, with the transporter adopting an
inward-facing conformation having the TMDs open to the cytoplasm and the NBDs widely
separated (Figure 1). The folds of MetN and MetI resemble those previously observed in the
ModBC (18) and MalFGK (19) transporters, with three principal differences: (i) the
transmembrane domain of the methionine transporter is smaller, as each MetI subunit
contains only five transmembrane helices per monomer, (ii) the structures of the methionine,
molybdate and maltose transporters represent a progression of inward-facing conformations
of the translocation pathway that vary from wide open to closed, respectively, and (iii) the
MetN ABC subunits contain a C-terminal extension that is distinct from those present in the
maltose and molybdate transporters, and that separate the NBDs in this inward-facing
conformation.
Each MetI subunit is organized around a core of five transmembrane helices that correspond
to a subset of the helices observed in the larger membrane spanning subunits of the
molybdate and maltose ABC transporters; the membrane spanning ModB, MalF and MalG
subunits in those transporters contain 6, 8 and 6 helices, respectively, with the common set
corresponding to the five most C-terminal helices in these structures (Figure 2A). The root
mean square deviations (rmsd) between equivalent Cα positions in MetN and these other
subunits are ∼2.5 Å. The region of highest sequence and structural similarity between these
structures coincides with the “coupling helix” and the two transmembrane helices on either
side (TM3 and TM4 in MetI). This region forms the core of the distinct conformations of the
translocation pathway observed in the methionine, molybdate and maltose transporters
(Figure 2B), with the coupling helix (including the consensus “EAA” motif (25, 26))
contributing significantly to the interface between the TMD and NBD subunits. The
sequence and structural homologies extend to TM2 in these structures, including the
relatively short length of this membrane spanning helix (∼14 residues) and the kinking at
Pro 67 near the periplasmic interface; these irregular features are not uncommon near the
translocation pathways of various transporters (17). One distinctive aspect of MetI is that it
contains an odd number of transmembrane helices, so that the N- and C-termini are on
opposite sides of the membrane (the periplasm and cytoplasm, respectively); this
arrangement contrasts with all other structurally characterized ABC transporters which
possess an even-number of transmembrane helices per TMD and have both termini in the
cytoplasm.
The MetN ABC subunit consists of two domains, the conserved NBD (residues 1-230),
homologous to other ABC subunits (rmsds to ModC and MalK ∼1 Å), and the C-terminal
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C2-domain (residues 265-343) that are connected by a linker of ∼35 residues. While the pair
of NBDs are approximately related by a two-fold axis, as are the pair of C2-domains, these
axes differ in orientation by ∼20°, which generates a pronounced asymmetry in the
transporter structure (Figure 1B). The distinct orientations of the rotation axes relating the
NBD pairs and the C2-domain pairs within a transporter are accommodated through
different conformations of the linker separating the NBD and C2-domains in the two MetN
subunits. The C2-domain exhibits a ferredoxin-like fold with a 4 stranded antiparallel β-
sheet (Figure 3A) that belongs to the ACT-domain family, proposed to represent a
conserved regulatory ligand binding fold (27-29). As with other members of this family, the
C2-domains from each MetN subunit in a transporter dimerize to form an 8-stranded β-
sheet; a similar arrangement is also observed in the structure of the isolated C2-domain
determined in the course of this project (24).
Since ATP binds to conserved sequence motifs at the interface between two closely
juxtaposed NBDs (30-33), the crystallographically observed inward-facing conformation of
the MetNI transporter corresponds to an ATPase-inactive state. The extent of separation of
the NBDs in this structure relative to other ABC importers (and the correlation between
NBD separation and the conformation of the translocation pathway) may be assessed from
the intersubunit distances between the P-loops and signature motifs of different ABC
subunits. Using the Cα residues of MetN residues Gly 43 and 143 to define the positions of
the P-loop and signature motifs, respectively, the intersubunit distances between these two
motifs are found to be 26-30 Å (the range reflects the asymmetry of this complex). For
comparison, the corresponding distances in the maltose and molybdate transporter structures
are ∼11 Å and ∼16 Å, respectively (based on the intersubunit distances between residues
Gly 36 and 129 of ModB, and Gly 41 and 136 of MalK, respectively), and were previously
reported as 14 Å and 16 Å in the structures of BtuCD and HI1470/71 (17). The short 11 Å
intersubunit distance observed in the maltose transporter between the P-loop and the
signature motif reflects both the closed interface between the NBDs and that the
translocation pathway is closed to the cytoplasm. While BtuCD has a somewhat larger
separation (14 Å) between NBDs than observed in the maltose transporter, the translocation
pathway is also closed to the cytoplasm. Although the intersubunit separation between
NBDs is only 2 Å longer in HI1470/71 and the molybdate transporter, the translocation
pathways in both structures are open to the cytoplasm, suggesting that this represents a
critical parameter relating the relative positioning of the NBDs to the conformation of the
translocation pathway. The ∼28 Å distance observed in the methionine structure is
significantly larger than the previously reported NBD separations in ABC importers and
suggests that the positioning of the C2-domain dimer is crucial for stabilizing this
arrangement.
To identify potential methionine binding sites, crystals of the wild-type methionine
transporter were soaked in 1 mM L-selenomethionine for two hours and diffraction data
were collected to 5.2 Å resolution at the selenium edge. Anomalous difference Fourier maps
revealed two binding sites for selenomethionine located near the dimer interface between
C2-domains (Figure 3A). The binding sites are located near the side chains of methionines
301 and 312 (Figure S2), although the resolution was insufficient to permit a detailed
modeling of the bound selenomethionine. The presence of ligand binding sites near the
dimer interface parallels observations on other ACT domain containing proteins (29).
Significantly, binding of serine to allosteric sites at the interface between ACT domains of
phosphoglycerate dehydrogenase results in a sequence of conformational changes that are
propagated to distinct catalytic domains (34). Evidence for the flexibility of the
corresponding interface in MetNI is provided by a ∼15° twist in the relative orientations
between C2-domains present in the transporter and in free form (Figure 3B), along with
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rearrangements of several loops, that could plausibly be influenced by the binding of
methionine.
The juxtaposition of the methionine binding C2-domains between the NBDs in the present
structure suggests they may be relevant to the transinhibition mechanism established by
Kadner (23). To test this proposal, the effect of methionine and methionine derivatives on
the ATPase activity of detergent solubilized transporter was characterized. Although this
assay does not directly monitor the influence of methionine on transport activity, it is
nevertheless appropriate to assess the ability of methionine to stabilize an ATPase-inactive
conformation of the transporter. As detailed in Figure 4, L-methionine does inhibit the
ATPase activity, with half-maximal inhibition occurring at ∼30 μM. L-Selenomethionine is
an even more potent inhibitor, with half-maximal inhibition occurring at ∼10 μM, while D-
methionine has little effect. As controls, truncation of the C2-domain, although reducing
ATPase activity under the assay conditions by ∼60%, eliminates the inhibitory effects of
methionine, while the E166Q mutant in the NBD (corresponding to a mutation shown to
prevent ATP hydrolysis in other systems (32)) exhibits little ATPase activity. These results
are consistent with a model where an equilibrium exists between conformational states of
MetNI differing in the extent of NBD displacement. Despite their separation in the crystal
structure of detergent solubilized MetNI, activity assays demonstrate that these domains can
associate to form an ATPase competent state. As methionine binds to the C2-domains, the
equilibrium shifts towards transporter conformations with separated NBDs, and as a
consequence, the rate of ATP hydrolysis decreases.
The structure of MetNI described here provides the first crystallographic analysis of a
member of the methionine uptake transporter family (3) of the superfamily of ABC
transporters. Beyond the relevance for the mechanistic understanding of this family, the
MetNI structure provides two general insights into the structural organization of ABC
importers - (i) a minimal core of 5 transmembrane helices is identified that may be
elaborated by additional helices in other transporters and (ii) a mechanistic basis is proposed
for the regulation of transport activity by domains fused to the core transporter. The binding
of methionine by the C2-domain at the C-terminus of the MetN subunit effectively stabilizes
the inward-facing, ATPase-inactive conformation of the transporter. By sterically interfering
with NBD association, the ATP-driven engine that powers transport will be disrupted,
thereby providing a molecular mechanism for Kadner’s observation that increasing levels of
internal methionine inhibit transport. The ability of methionine, and particularly
selenomethionine, to inhibit transport further suggests that the deletion of the C2-domain
from the endogenous methionine transporter of E. coli strains used for selenomethionine
labeling may increase the incorporation efficiency by allowing uptake to a higher
intracellular concentration. Of a more general consideration, transporter activity can
represent a major component of the ATP requirement of bacteria (35, 36). Consequently, it
is not surprising that transporters can be regulated at the level of protein function to more
efficiently control the allocation of cellular energy resources. The structure of the MetNI
ABC transporter provides a foundation for the characterization of regulatory mechanisms
relevant to the uptake of methionine, and how these processes are more generally integrated
with cellular metabolism.
The recent report by Gerber et al. (published online Science DOI: 10.1126/science.1156213)
details the structural basis of trans-inhibition of the ModBC molybdate ABC transporter
from Methanosarcina acetivorans; although the molybdate/tungstate binding C-terminal
regulatory domain of ModC has a distinct fold from the methionine binding C2-domain of
MetN, the consequences for transporter conformation are quite similar.
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(A) The ABC transporter MetNI consists of four subunits: two membrane-spanning MetI
subunits (green and pink) and two MetN ABC subunits (purple and tan). The molecular
rotation axis relating the MetI subunits is vertical, with the cytoplasmic (inward) facing
surface of the transporter towards the bottom. The C2-domains forming the dimer interface
between MetN subunits are at the bottom. (B) A view of MetNI rotated ∼90° about the
vertical axis from that of (A), illustrating the asymmetrical orientation of the C2 domains
relative to the MetI subunits and the MetN nucleotide binding domains. This figure was
prepared and rendered with PyMOL (38).
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(A) Superposition of the five membrane spanning helices forming the common core of the
transmembrane domains of MetI (yellow), ModB (green), MalF (blue) and MalG (light
blue). TM1 (using the MetI number) is oriented diagonally across the front, while remaining
helices are arranged in the sequence TM2 to TM5, from left to right. The coupling helices
between TM3 and TM4 are the helical elements at the bottom of the figure. (B) Comparison
of the TM2-TM3-TM4 helices lining the translocation pathways of MetI (brown), ModB
(green) and MalFG (blue), illustrating the progressive narrowing of cytoplasmic opening of
the translocation pathway in the sequence from the methionine to molybdate to maltose
transporters. The views in this figure are from the membrane, with the cytoplasmic surface
oriented down. Figures 2 and 3 were prepared with MOLSCRIPT and RASTER3D (39, 40).
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(A) Anomalous difference Fourier map calculated at 5.2 Å resolution illustrating the binding
of selenomethionine to the C2-domains of MetNI following a 1 mM soak of transporter
crystals. The electron density is contoured at 6 times the standard deviation of the map. (B)
Comparison of the relative orientations of C2-domains observed in the MetNI and free
MetN-C2 structures, following superposition of one subunit in each dimer. The green and
dark gray traces correspond to the C2-domain dimer in MetNI, while the magenta and light
gray traces represent the isolated C2-domain structure. The binding site for
selenomethionine is denoted by the gold surface. The view is roughly perpendicular about
the horizontal axis from that in (A).
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Dependence of the ATPase activity of various MetNI constructs on the concentration of
methionine analogues. The ATPase activity was measured from the rate of phosphate
production as assayed by the method of Webb (41), and converted to moles phosphate/
minute/mole transporter. An initial ATP concentration of 1 mM was used, which is ∼3 times
the apparent Km (Figure S3). The blue diamonds, black squares and green triangles
correspond to L-methionine, D-methionine and L-selenomethionine, while the open blue
and red circles represent the effect of L-methionine on the E166Q (ATPase-inactive mutant)
and the ΔC2-MetNI truncation mutant, respectively. The error bars represent the standard
deviations calculated from 8 measurements.
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